Literature DB >> 6350492

Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy.

T L Gustafson, W Schaffner, G B Lavely, C W Stratton, H K Johnson, R H Hutcheson.   

Abstract

During a 31-month period in 1979-1981, nine patients at a renal transplant center in Tennessee developed invasive infections with Aspergillus species. Despite an extensive search, no common environmental source of contamination was found. A matched case-control study of host risk factors showed that leukopenia, prior administration of antibiotics, and treatment with azathioprine and antilymphocyte serum were not significantly related to the development of aspergillosis. In contrast, the administration of high-dose corticosteroids posed a significant risk. An average daily dose of greater than or equal to 1.25 mg of prednisone/kg per day for the entire interval studied was the best predictor of subsequent invasive infection with Aspergillus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6350492     DOI: 10.1093/infdis/148.2.230

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Endocarditis by Aspergillus fumigatus in a renal transplant.

Authors:  P Marín; P García-Martos; A García-Doncel; A García-Tapia; E Aznar; J Perez Requena; S Valverde
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

Review 2.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  Invasive aspergillosis in immunosuppressed patients: potential hazard of hospital building work.

Authors:  A G Dewhurst; M J Cooper; S M Khan; A P Pallett; J R Dathan
Journal:  BMJ       Date:  1990-10-06

Review 4.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 5.  Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature.

Authors:  Joel W Alderson; Thomas G Van Dinter; Michael J Opatowsky; Elizabeth C Burton
Journal:  MedGenMed       Date:  2005-09-21

6.  Tilletiopsis minor: a new etiologic agent of human subcutaneous mycosis in an immunocompromised host.

Authors:  R Ramani; B T Kahn; V Chaturvedi
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

Review 7.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

8.  Specific interaction of Aspergillus fumigatus with fibrinogen and its role in cell adhesion.

Authors:  P Coulot; J P Bouchara; G Renier; V Annaix; C Planchenault; G Tronchin; D Chabasse
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence.

Authors:  H F Tsai; Y C Chang; R G Washburn; M H Wheeler; K J Kwon-Chung
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

Review 10.  Fungal infections: a growing threat.

Authors:  D M Dixon; M M McNeil; M L Cohen; B G Gellin; J R La Montagne
Journal:  Public Health Rep       Date:  1996 May-Jun       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.